William J. Enright
Net Worth
Last updated:
What is William J. Enright net worth?
The estimated net worth of Mr. William J. Enright is at least $1,182,060 as of 27 Mar 2023. He has earned $36,300 from insider trading and has received compensation worth at least $1,145,760 in Vaccitech plc.
What is the salary of William J. Enright?
Mr. William J. Enright salary is $572,880 per year as Chief Executive Officer & Board Director in Vaccitech plc.
How old is William J. Enright?
Mr. William J. Enright is 62 years old, born in 1963.
What stocks does William J. Enright currently own?
As insider, Mr. William J. Enright owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Vaccitech plc (VACC) | Chief Executive Officer & Board Director | 728,454 | $0 | $0 |
What does Vaccitech plc do?
Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.
William J. Enright insider trading
Vaccitech plc
Mr. William J. Enright has made only one insider trade in 2023, according to the Form 4 filled with the SEC. He sold 15,000 units of VACC stock worth $36,300 on 27 Mar 2023.
As of 27 Mar 2023 he still owns at least 728,454 units of VACC stock.
Vaccitech key executives
Vaccitech plc executives and other stock owners filed with the SEC:
- Mr. William J. Enright (62) Chief Executive Officer & Board Director